Skip to main content

JPMORGAN CHASE & CO

Position in LLY — ELI LILLY & Co

CIK 19617 NEW YORK, NY

Position in LLY

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$12,599,461,057
-$1,369,172,838 QoQ
Shares Held
13,698,491
+5.4% QoQ
Ownership
1.45%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 80.62548641306549.ToString("F0")% Shared 0.43511361944903276.ToString("F0")% None 18.93939996748547.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $65,165,946,852 across 18 Drug Manufacturers - General names. LLY ranks #2 (19.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 LLY
ELI LILLY & Co
This page
13,698,491 $12,599,461,057

All Filings in LLY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,599,461,057 13,698,491
2025-12-31 $13,968,633,895 12,997,946
2025-09-30 $7,834,602,265 10,268,155
2025-06-30 $9,752,678,775 12,510,973
2025-03-31 $11,133,199,064 13,479,918
2024-12-31 $11,514,179,280 14,914,740
2024-09-30 $16,182,687,225 18,266,121
2024-06-30 $17,078,659,160 18,863,526
2024-03-31 $14,976,480,720 19,250,965
2023-12-31 $11,310,707,445 19,403,533
2023-09-30 $8,488,368,511 15,803,192
2023-06-30 $6,631,196,161 14,139,614
2023-03-31 $3,747,229,038 10,911,505
2022-12-31 $5,860,632,770 16,019,661
2022-09-30 $4,772,139,949 14,758,435
2022-06-30 $5,023,968,159 15,495,075
2022-03-31 $4,666,751,949 16,296,232
2021-12-31 $4,695,153,856 16,997,878
2021-09-30 $3,624,003,993 15,684,934
2021-06-30 $3,934,665,253 17,143,017
2021-03-31 $3,238,117,796 17,332,822
2020-12-31 $3,632,870,165 21,516,644
2020-09-30 $2,789,055,738 18,842,425
2020-06-30 $2,617,420,599 15,942,384
2020-03-31 $2,407,653,303 17,356,209